Overview of Movement Disorders Market: Hospitals to Generate Significant Revenues through 2026, Forecast Report By Fact.MR

Posted on 2018-06-20 by Mark Hub in Healthcare // 0 Comments

Fact.MR

Rockville, US, 2018-Jun-20 — /EPR Network/ — Fact.MR research firm has recently updated its massive report catalogue by adding a fresh study titled “Movement Disorder Market Research Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026”. This business intelligence study encapsulates vital details about the market current as well as future status during the forecast period of 2017-2026. Readers can expect holistic and comprehensive analysis on the movement disorders market, which can be used for formulating effective business strategies. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated to growth of manufacturers in global market for movement disorders market.

Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=329

Factors Fueling Global Market Growth

Growth of the global movement disorders market is projected to be bound by various macro-economic and micro-economic factors. Lack of ability to move due to growing prevalence of factors such as cerebrovascular diseases, trauma, brain tumors, degenerative diseases and convulsive diseases continues to impact the global market growth of movement disorder positively. Prevalence of neurological disorders negatively affect the cognitive abilities and lead to depression, incapability to chew, swallowing, speaking and insomnia. Growing awareness regarding the prevalence of various mental diseases will further contribute towards the global market growth of movement disorder significantly.

Treatments and medications that have received an approval from FDA will further impact the global market growth of movement disorders positively. Ingrezza capsules and Xadago (safinamide) tablets are two medicines that have received an approval from FDA recently. Xadago (safinamide) tablets has been approved for the treatment of Parkinson’s disease and Ingrezza capsules has been approved for the treatment of dyskinesia. Moreover, FDA has approved brain transplantation in order to reduce various symptoms of tremor. Such factors continue to impact the global market growth of movement disorder significantly.

Sales to Remain High in Hospitals

Treatment of various neurological diseases has led to surge in adoption of the rechargeable deep brain stimulator devices. The rechargeable deep brain stimulator devices is projected to outsell the non-rechargeable deep brain stimulator devices globally. On the basis of product type, the rechargeable deep brain stimulator devices is projected to witness the highest growth in terms of revenue, recording more than US$ 500 Mn by 2026-end. On the other hand, the non-rechargeable deep brain stimulator devices product type segment is projected to reflect a robust CAGR throughout the forecast period.

By end user, the hospitals segment is projected to represent a robust revenue growth, accounting for less than US$ 100 Mn by 2017-end. In contrary to this, the clinics end user segment is projected to reflect a healthy CAGR during the forecast period. In terms of revenue, the parkinson’s disease application segment is projected to witness a significant revenue growth, recording more than US$ 400 Mn by 2026-end. By 2026-end, the dystonia application segment is projected to witness the fastest growth during the forecast period.

Market Players

Major players in the global market of movement disorder are Abbott Laboratories, Medtronic Plc, Mayo Clinic and Boston Scientific Corporation.

View Full Report with TOC@ https://www.factmr.com/report/329/movement-disorder-market

Table of Contents:

Chapter 1 Global Outlook

Chapter 2 Global Movement Disorder Market – Executive Summary

Chapter 3 Global Movement Disorder Market Overview
3.1 Introduction
3.1.1 Global Movement Disorder Market Taxonomy
3.1.2 Global Movement Disorder Market Definition
3.2 Global Movement Disorder Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1 Global Movement Disorder Market Y-o-Y Growth
3.3 Global Movement Disorder Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Technology Roadmap
3.7 Disease Epidemiology
3.8 Product Lifecycle
3.9 Key Regulations
3.10 PESTL Analysis
3.11 List of Service Providers
3.12 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Movement Disorder Market Analysis and Forecast 2012-2026
4.1 Global Movement Disorder Market Size and Forecast by Product Type, 2012-2026
4.1.1 Rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
4.1.1.1 Revenue (US$ Mn) Comparison, By Region
4.1.1.2 Market Share Comparison, By Region
4.1.1.3 Y-o-Y growth Comparison, By Region

Continued………

Buy this Report@ https://www.factmr.com/checkout/329/S

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick